FILE:AGN/AGN-8K-20020813153728.txt.gz
EVENTS:	
TEXT:
ITEM: 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Item 9.    Regulation FD Disclosure.
 
Certifications Required Pursuant to Section 21(a)(1) of the Securities Exchange Act of 1934
 
On August 13, 2002, the Principal Executive Officer and the Principal Financial Officer of Allergan, Inc. (the "Company") each signed the statement under oath required by the Securities and Exchange Commission Order of June 27, 2002. Pursuant to the Statement by the Staff of the Securities and Exchange Commission on July 29, 2002, the two statements under oath are set forth below:
 
Statement Under Oath of Principal Executive Officer Regarding Facts and Circumstances Relating to Exchange Act Filings
 
I, David E.I. Pyott, Chairman of the Board, President and Chief Executive Officer of Allergan, Inc., state and attest that:
 
 
 
 
 
 
 
 
 
 
 
 
Statement Under Oath of Principal Financial Officer Regarding Facts and Circumstances Relating to Exchange Act Filings
 
I, Eric K. Brandt, Corporate Vice President and Chief Financial Officer of Allergan, Inc., state and attest that:
 
 
 
 
 
 
 
 
 
 
 
Certification Required by 18 U.S.C.  1350
 
On August 12, 2002, the Company filed its Quarterly Report on Form 10-Q for the quarterly period ended June 28, 2002 (the "Form 10-Q") with the Securities and Exchange Commission. In connection with the filing of the Form 10-Q, the Company has provided to the Securities and Exchange Commission the certifications below, as required by 18 U.S.C.  1350, as created by Section 906 of the Sarbanes-Oxley Act of 2002:
 
 
Pursuant to 18 U.S.C.  1350, as created by Section 906 of the Sarbanes-Oxley Act of 2002, the undersigned officer of Allergan, Inc., a Delaware corporation (the "Company"), hereby certifies, to such officer's knowledge, that:
 
(i)         the accompanying Quarterly Report on Form 10-Q of the Company for the quarterly period ended June 28, 2002 (the "Report") fully complies with the requirements of Section 13(a) or Section 15(d), as applicable, of the Securities Exchange Act of 1934, as amended; and
 
(ii)        the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
 
 
The foregoing certification is being furnished solely to accompany the Report pursuant to 18 U.S.C.  1350, and is not being filed for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, and is not to be incorporated by reference into any filing of the Company, whether made before or after the date hereof, regardless of any general incorporation language in such filing.
 
 
Pursuant to 18 U.S.C.  1350, as created by Section 906 of the Sarbanes-Oxley Act of 2002, the undersigned officer of Allergan, Inc., a Delaware corporation (the "Company"), hereby certifies, to such officer's knowledge, that:
 
(i)         the accompanying Quarterly Report on Form 10-Q of the Company for the quarterly period ended June 28, 2002 (the "Report") fully complies with the requirements of Section 13(a) or Section 15(d), as applicable, of the Securities Exchange Act of 1934, as amended; and
 
(ii)        the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
 
 
The foregoing certification is being furnished solely to accompany the Report pursuant to 18 U.S.C.  1350, and is not being filed for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, and is not to be incorporated by reference into any filing of the Company, whether made before or after the date hereof, regardless of any general incorporation language in such filing.
 
 
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 


